FutureFuel Shakes Off a Decade of Silence
First earnings call in over a decade arrives with a return to profitability, a 45Z monetization deal, and customer-funded capacity expansion.
FF · Earnings Call · 2026-08-11
The First Call in a Decade
FutureFuel (FF) held its first quarterly earnings call in over a decade on August 11, 2026 — a symbolic break with a historically reticent IR posture. Chairman and CEO Roeland H. Polet framed it as part of a broader "reintroduction" of the company. The call came alongside a qualitative beat: revenue of $78.7M, up 120% YoY, and a swing to $11.4M net income from a $14.2M loss a year earlier. Polet attributed the improvement to "strengthening end market demand, improved production economics, continued cost discipline and enhanced optimization of our Batesville plant." “The second quarter marked a return to profitable growth for FutureFuel.” — Roeland H. Polet, Chairman and Chief Executive Officer · 2026-08-11 That statement is backed by a Batesville complex that has been underutilized for years; the company is finally running it at higher rates. The CEO, who spent 35 years in specialty chemicals before joining in late 2024, touted the site's unique history: “Our history dates back to, the Kodak days. And this plant made photographic chemicals as well as was set up to make sort of precursors to the pharmaceutical industry.” — Roeland H. Polet, Chairman and Chief Executive Officer · 2026-08-11 That heritage gives FutureFuel a moat in complex, dangerous chemistries — a theme echoed in the company's keyword momentum around dangerous chemistry.The 45Z Catalyst and a New Commercial Model
The most concrete new catalyst is the monetization of Section 45Z clean fuel tax credits. CFO Rose Sparks confirmed a four-year agreement with a third party: “So, yes, the amount that we have quoted is for 2026 and 2025. So there is approximately $3 million that we will be able to cash in Q3. And then there will be an additional $19 million on a gross basis that we will cash in December of this year.” — Rose Sparks, Chief Financial Officer · 2026-08-11 That $22M gross proceeds — offsetting elevated feedstock costs — is a direct result of the improved regulatory clarity around the 45Z credit. It also reduces the volatility that has historically plagued the Biofuel segment. Underlying this is a strategic shift toward contract manufacturing, as Polet explained: “Our business model is, you know, we do biodiesel. And we have a, and we run chemicals. Right? In our chemicals division, we have some proprietary chemicals that we make for our ourselves and we market. But the majority of our business is contract manufacturing.” — Roeland H. Polet, Chairman and Chief Executive Officer · 2026-08-11 He further described a pipeline of customer-funded capacity expansions. On the call, he revealed that one customer is investing over $40M over three years to support incremental capacity, and that the company is "doubling or tripling" that expansion. This customer co-investment model is a powerful differentiator — it lowers FF's capital risk while embedding the producer deeper into its customers' supply chains.What's Different This Time
The contrast with the company's last formal earnings calls (circa 2015) is stark. In November 2015, then-CEO Paul Flynn was dealing with a one-time termination payment: “I think obviously the big data points in this quarter is obviously $8.8 million one-time termination payment for the comp that graphite material contract...” — Paul Flynn, CEO · 2015-11-11 In May 2015, Flynn's focus was internal execution: “So, a couple of comments on that, Craig, is our primary focus over the last six months has really been internally focused on executing better.” — Paul M. Flynn - Executive Vice President, Business and Marketing, FutureFuel Corp., Executive Vice President, Business and Marketing · 2015-05-12 Those themes are now resurfacing, but with a new twist: the company has finally begun to build a track record of commercial production wins and regulatory tailwinds that were absent a decade ago. The financial reality is also inflecting. The fundamentals show revenue collapsing from a peak of $121M in 2022Q3 to lows of $18M in 2025Q1 — a -77% drawdown. But the latest filings and the Q2 call point to a sharp reversal: Total Revenue reached $32M in 2026Q1 and, on the call, $78.7M for Q2. That momentum is also visible in capacity utilization: chemical segment utilization rose to 65% from 54% a year ago, and biofuel utilization hit 56% despite a three-week outage.The Market's Verdict
Yet the market has been lukewarm. Since the call — which took place on August 11, 2026 — the stock is down about 5% (trading at $5.85 on the day after the call, down to $5.56 by August 21). This might reflect skepticism about whether the 45Z monetization and the customer-funded expansions can sustain the rebound, especially with input costs still elevated. Polet acknowledged the risk: “if there is a shock in soybean oil, you know, that could have a negative effect.” — Roeland H. Polet, Chairman and Chief Executive Officer · 2026-08-11 But he also expects input costs to mean-revert, which would be a tailwind.For a micro-cap that has been largely ignored for a decade, this call marks a genuine inflection point. The combination of a new CEO, a renewed focus on contract manufacturing, the 45Z monetization, and customer-funded expansions creates a credible path to sustained value creation — if the execution follows through.We believe we have a great business here. We also believe that we need to be more transparent with our investor base, and we intend to do so through investor presentations and further calls.